ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)
Study sponsor: Aligos Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-08-19Actual
Enrollment · participants102Actual
Source updated2025-02-17Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.